Operation of the Audit Committee

Board/Functional Committee

Operation of the Audit Committee

In 2025, the Audit Committee has convened 5 meetings. the attendance of independent directors is as follows:

Title	Name	Actual Attendance	Attendance Rate (%)
Independent Director	Yang Yung Cheng	5	100.00
Independent Director	Lee Wen Chuan	5	100.00
Independent Director	Juan Chiung Hua	5	100.00
Independent Director	Ho Chia Fang	5	100.00

In 2024, the Audit Committee has convened 6 meetings. the attendance of independent directors is as follows:

Title	Name	Actual Attendance	Entrusted to Attend Frequency	Attendance Rate (%)
Independent Director	Yang Yung Cheng	6	0	100.00
Independent Director	Lee Wen Chuan	5	1	83.33
Independent Director	Juan Chiung Hua	6	0	100.00
Independent Director	Ho Chia Fang	5	1	83.33

Work priorities

Review of quarterly financial statements.
Review annual business report, financial statements and profit distribution
Review the revision of internal control system.
Appointing external auditors, review independence and fees.

Items to be recorded

If the operation of the audit committee is in any of the following circumstances, the date, period, proposal content, resolution of audit committee and the company’s handling of independent committee members ‘opinions shall be stated:

The matters listed in Article 14(5) of Securities and Exchange Act:

Session	Date	Meeting Content	Resolutions and the Company’s handling to Audit Committee's opinions
13th time of the 5th committee	2024.03.14	2023 consolidate financial report and business report The company will change external auditor from 2024 Approval of accountant remuneration and competency 2023 earnings distribution proposal Ratify the appointment and dismissal of the company's current internal audit officer 2023 internal audit system statement	All presented members approved without objection and submitted to the board of directors for discussion.
14th time of the 5th committee	2024.04.18	The Company intends to loan to its Indonesian subsidiary PT All Cosmos Biotek (hereinafter referred to as PT Biotek)	All presented members approved without objection and submitted to the board of directors for discussion.
15th time of the 5th committee	2024.05.13	Approval of consolidated financial statements for the first quarter of 2024	All presented members approved without objection and submitted to the board of directors for discussion.
16th time of the 5th committee	2024.08.27	Approval of consolidated financial statements for the second quarter of 2024 The Company’s derivatives trading quota and trading situation Proposal of subsidiary ACI’s loan to ACBT	All presented members approved without objection and submitted to the board of directors for discussion.
17th time of the 5th committee	2024.11.12	Approval of consolidated financial statements for the third quarter of 2024 Change of new internal audit officer Proposal of ACI purchasing industrial land (Lot No. PTD 243585, Title No. HSD 605649, Tanjung Puteri Resort, Pasir Gudang, Johor) Amendment of “Rules of procedure of board of directors”, “Organization rules of audit committee” and “Corporate governance practice guidelines”	All presented members approved without objection and submitted to the board of directors for discussion.
18th time of the 5th committee	2024.12.16	Formulate the company's "Sustainable Information Management Operation Guidelines Approval of 2025 internal control system	All presented members approved without objection and submitted to the board of directors for discussion.
19th time of the 5th committee	2025.03.13	2024 consolidate financial report and business report Approval of accountant remuneration and competency 2024 earnings distribution proposal 2024 earning capital conversion and new share issuance Endorsement guarantee for ACI 2024 internal audit system statement	All presented members approved
20th time of the 5th committee	2025.05.13	Approval of consolidated financial statements for the first quarter of 2025 Non-assurance services provided by accountant Extension of loan to subsidiary PT All Cosmos Biotek (PT Biotek)	All presented members approved
2nd time of the 6th committee	2025.07.04	Endorsement guarantee for subsidiary PT All Cosmos Biotek (PTACB)	All presented members approved
3rd time of the 6th committee	2025.08.26	Approval of consolidated financial statements for the second quarter of 2025 Extension of loan from subsidiary ACI to All Cosmos Bio-Tech Holding Corporation	All presented members approved

2. Other resolutions that have not been approved by the Audit Committee but have been approved by more than two-thirds of all directors in addition to previous matters: None

The implementation of independent directors' avoidance of the proposal of interest, should state independent director’s name, contents of proposal, reasons for avoidance, participation and voting status: None.

Performance evaluation

Cycle	Period	Scope	Method	Content
Annually	2024/01/01 \| 2024/12/31	Audit committee performance evaluation	self-evaluation	The audit committee performance evaluation includes the following five aspects: Degree of participation in company operations Recognition of the responsibilities of functional committees Improve the decision-making quality of functional committees Functional committee composition and member selection Internal Control

Cycle

Period

Scope

Method

Content

Annually

2024/01/01
|
2024/12/31

Audit committee performance evaluation

self-evaluation

The audit committee performance evaluation includes the following five aspects:

Degree of participation in company operations
Recognition of the responsibilities of functional committees
Improve the decision-making quality of functional committees
Functional committee composition and member selection
Internal Control

The performance of the Company's Audit Committee is as follows, based on the above table and using an internal questionnaire:

All committee members believed that the situations described in each of the questions below in the questionnaire were well performed, indicating that the overall operation of the committee was sound and effectively enhanced the functions of the board of directors.